CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis).

about

NHL (diffuse large B-cell lymphoma).Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care

P2860

Q33846734-1C73777F-64E5-446C-A67A-C6D0097F4962 Q35776255-C55A85FD-BF5A-47BD-8AAF-8C4FB3F4EF02

P2860

CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis).

Item

http://www.wikidata.org/entity/Q46709432

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

CNOP (mitoxantrone) chemothera ...... gkin lymphoma (meta-analysis).

@en

CNOP

@nl

type

Item

label

CNOP (mitoxantrone) chemothera ...... gkin lymphoma (meta-analysis).

@en

CNOP

@nl

prefLabel

CNOP (mitoxantrone) chemothera ...... gkin lymphoma (meta-analysis).

@en

CNOP

@nl

P1476

CNOP (mitoxantrone) chemothera ...... gkin lymphoma (meta-analysis).

@en

P2093

Eva Ösby

http://www.w3.org/2001/XMLSchema#string

Magnus Björkholm

http://www.w3.org/2001/XMLSchema#string

Tomas Andersson

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

Reproducibility of tumor response evaluation in patients with high-grade malignant non-Hodgkin's lymphoma.

Treatment of large cell lymphoma in elderly patients with a mitoxantrone, cyclophosphamide, etoposide, and prednisone regimen: long-term follow-up results.

The role of mitoxantrone in the treatment of indolent lymphomas.

The role of pixantrone in the treatment of non-Hodgkin's lymphoma.

Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma.

Advanced diffuse histiocytic lymphoma, a potentially curable disease.

Cancer chemotherapy in older adults. A tolerability perspective.

Long-term results of a multicentre randomised, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate- and high-grade non-Hodgkin's lymphomas. Novantrone International Study Group.

Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO.

P304

477-482

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1111/J.1600-0609.2008.01062.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anders Ahlbom

P577

2008-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18331601

http://www.w3.org/2001/XMLSchema#string

CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis).

about

P2860

P2860

CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698